Complexins constitute a family of four synaptic high-affinity SNARE complex-binding proteins. They positively regulate a late, post-priming step in Ca 2+ -triggered synchronous neurotransmitter release, but the underlying molecular mechanisms are unclear. We show here that SNARE complex binding of complexin I (CplxI) via its central a-helix is necessary but, unexpectedly, not sufficient for its key function in promoting neurotransmitter release. An accessory a-helix on the N-terminal side of the SNARE complex-binding region has an inhibitory effect on fast synaptic exocytosis, whereas sequences N-terminally adjacent to this helix facilitate Ca 2+ -triggered release even in the absence of the Ca 2+ sensor synaptotagmin-1. Our results indicate that distinct functional domains of CplxI differentially regulate synaptic exocytosis and that, through the interplay between these domains, CplxI carries out a crucial role in fine-tuning Ca 2+ -triggered fast neurotransmitter release.
The precise timing of neurotransmitter release is crucial for information processing in the nervous system. To achieve this exquisite regulation, release is controlled by a complex protein apparatus. Central components of this machinery are the soluble N-ethylmaleimidesensitive factor attachment protein receptors (SNAREs)-synaptobrevin-2, syntaxin-1 and SNAP-25-which belong to a conserved family of membrane-associated proteins with a central role in membrane fusion 1 . The SNAREs form a tight four-helix bundle, the SNARE complex, through sequences called SNARE motifs 2, 3 . SNARE complex formation brings the vesicle and plasma membrane into close apposition, which is likely to be essential for membrane fusion 1, 4 . Among additional factors that are required to facilitate the extreme speed and exquisite Ca 2+ sensitivity of vesicle fusion at synapses, synaptotagmin-1 (Syt1), which acts as a Ca 2+ sensor 5 , and complexins (Cplx, also called synaphins) are particularly important.
Complexins are encoded by four genes (CplxI through CplxIV) and constitute a family of small (15-to 18-kDa), acidic proteins [6] [7] [8] [9] . Complexins bind the assembled SNARE complex, but not individual SNAREs, through a central a-helix that interacts with the SNARE motifs of syntaxin-1 and synaptobrevin-2 (refs. 8, [10] [11] [12] [13] [14] [15] . In addition, complexins contain an accessory a-helix that does not contact the SNARE complex 12 , and additional N-and C-terminal sequences with unknown function.
Studies on CplxI and CplxII double-knockout (CplxI/II DKO) mice have indicated that CplxI and CplxII are crucial positive regulators of synaptic vesicle exocytosis in vivo that act at the Ca 2+ -triggering step of neurotransmitter release 16 . Cross rescue experiments have shown that CplxIII and CplxIV can functionally replace CplxI and CplxII in hippocampal glutamatergic neurons, indicating that CplxIII and CplxIV also act as positive regulators of neurotransmitter release 9 . Several studies have confirmed that complexins promote transmitter release 17, 18 , but others have indicated an inhibitory function for complexins 19, 20 . Recent reports using reconstituted liposome and cell fusion assays have indicated that complexins act as 'clamps' of SNARE-mediated membrane fusion, which is released by Ca 2+ -bound Syt1 (refs. 21,22) . Another observation also indicates an inhibitory role for complexins in release: a fusion protein of CplxI and synaptobrevin-2 outcompetes Syt1 for SNARE complex binding and abrogates Ca 2+ -triggered synchronous release 23 . These studies also indicate that complexins and Syt1 may be functionally coupled. Furthermore, deletion of Syt1 abolishes synchronous release while asynchronous release remains intact, which is similar to, but more severe than, the CplxI/II DKO phenotype 24, 25 . Therefore, it has been proposed that complexins fully assemble the SNARE complex and transform vesicles into a metastable state that serves as the substrate for Syt1 to trigger fast release 12, 23, 26 .
Complexins are crucial in regulating synaptic exocytosis, but the precise molecular mechanism and structural basis of their function remain unclear. To shed light on these questions, we performed a detailed quantitative structure-function analysis of CplxI in mouse hippocampal glutamatergic synapses. Our data show that binding of the central a-helix to the SNARE complex is essential for CplxI function. At the same time, the results of this analysis provide strong evidence for the physiological importance of the SNARE complex itself in neurotransmitter release. Furthermore, we found that the accessory a-helix of CplxI has an inhibitory effect on release, whereas the first 26 residues of CplxI have a crucial facilitatory function that may be associated with a novel interaction. The dual functions of the N terminus of CplxI require binding of the SNARE complex. These results show that different domains of CplxI have distinct functions in promoting or inhibiting Ca 2+ -triggered release, indicating that an intricate interplay between these domains is essential in fine-tuning the speed and the Ca 2+ sensitivity of neurotransmitter release.
RESULTS

Overexpression of CplxI rescues
CplxI/II DKO CplxI/II DKO hippocampal glutamatergic neurons show reduced vesicular release probability (P vr ), increased paired-pulse ratio and decreased Ca 2+ sensitivity of synchronous release 16 . For our systematic structure-function analysis of CplxI, we used a knockout-rescue approach where these three synaptic characteristics served as readouts for CplxI function (see Methods).
We first compared CplxI/II DKO neurons overexpressing wild-type (WT) CplxI via Semliki Forest virus (SFV) 27 with unrescued CplxI/II DKO neurons and control neurons (CplxII knockout neurons, which are indistinguishable from WT neurons 16 ) (Fig. 1) . The amplitudes of action potential-evoked excitatory postsynaptic currents (EPSC) were reduced by 58% in CplxI/II DKO neurons. Overexpression of WT CplxI in CplxI/II DKO neurons restored the EPSC amplitudes to the magnitudes seen in controls (Fig. 1a,e) . The sizes of the readily releasable pools of vesicles (RRP) measured using hypertonic solution 28 were not significantly different among the three groups (P ¼ 0.7; Fig. 1b,f) . Consequently, P vr was reduced by 46% in CplxI/II DKO neurons, whereas the P vr of CplxI/II DKO neurons rescued with WT CplxI was indistinguishable from that of control neurons (Fig. 1g) . The altered synaptic short-term plasticity of CplxI/II DKO neurons, detected by measuring five EPSCs at 50 Hz (or 20-ms interstimulus interval (ISI)), was changed to the characteristics of control neurons upon overexpression of WT CplxI (Fig. 1c,h ). The reduced apparent Ca 2+ sensitivity of synchronous release in CplxI/II DKO neurons was also restored by overexpression of WT CplxI (Fig. 1d,i,j) . The degrees of EPSC amplitude potentiation or depression upon switching from standard Ca 2+ concentrations (4 mM Ca 2+ , 4 mM Mg 2+ ) to high Ca 2+ concentrations (12 mM Ca 2+ , 1 mM Mg 2+ ; Fig. 1i ) or low Ca 2+ concentrations (1 mM Ca 2+ , 1 mM Mg 2+ ; Fig. 1j) were similar between the rescue and control groups.
Together, the above data show that the temporary lack of CplxI and CplxII does not cause irreversible effects on synaptic function and that overexpression of WT CplxI can fully reconstitute WT-like synaptic function in CplxI/II DKO neurons.
Synaptic function is not sensitive to complexin abundance
The fusion-clamp model of complexins predicts that an elevated abundance of complexins may inhibit neurotransmitter release 21, 22 . Moreover, CplxII is downregulated in several neurological disorders, including a transgenic mouse model of Huntington's disease 29 . We therefore examined the sensitivity of synaptic function to altered complexin abundance in our genetically well-characterized system. We studied neurons lacking CplxII and containing only one functional CplxI allele (CplxI Het CplxII KO) to test the sensitivity of synaptic function to a large reduction in complexins 16 . We also examined whether more than ten-fold overexpression of CplxI (Supplementary Fig. 1a online) transmission, as evoked EPSC amplitude, RRP size, P vr , paired-pulse ratio and Ca 2+ sensitivity were not significantly changed (P 4 0.05 for all tested parameters; Fig. 2 and data not shown). Thus, at hippocampal glutamatergic synapses, transmitter release is not sensitive to either severe reduction or strong elevation of complexin abundance. CplxI and CplxII have a steady positive effect on Ca 2+ -triggered neurotransmitter release over a wide range of expression levels. Hence, complexins do not act merely as fusion clamps in synaptic exocytosis.
Mutations in CplxI that block SNARE complex binding
To test the functional significance of complexin binding to the SNARE complex, we identified CplxI mutants with deficient SNARE complex binding, first by random mutagenesis 30 and then by site-directed mutagenesis based on the structure of the CplxI-SNARE complex 12, 13 .
In the random mutagenesis experiments, we generated 20 independent full-length CplxI clones encoding missense mutations in CplxI (Fig. 3a) . Glutathione S-transferase (GST)-tagged WT CplxI and mutants were tested for binding to the SNARE complex in cosedimentation assays. None of the missense mutations outside of the previously defined SNARE complex-binding region (residues 48-70 of CplxI 12 ) influenced the interaction with the neuronal SNARE complex ( Fig. 3a-c ; data not shown). Three single mutations (R48L, R59H and G71D) perturbed SNARE complex binding, and the double mutation R48L R59H abolished the binding ( Fig. 3b-d ).
The structure of the CplxI-SNARE complex indicates that two tyrosine residues (Tyr52 and Tyr70), three arginine residues (Arg48, Arg59 and Arg63) and one lysine residue (Lys69) of CplxI are crucial for binding to the SNARE complex 12 . We mutated these residues (Y52A, R63A or K69A Y70A) and found that SNARE complex binding was either strongly reduced (Y52A) or abolished (R63A and K69A Y70A; Fig. 3d ). Together, these data verify the predictions of the structural studies and demonstrate that individual amino acid residues in the central part of CplxI are essential for SNARE complex binding.
SNARE complex binding is necessary for CplxI function
To investigate the functional relevance of CplxI binding to the SNARE complex in vivo, we examined the rescue activities of SNARE complex binding-deficient CplxI mutants in CplxI/II DKO neurons. In this series of experiments, we compared CplxI/II DKO neurons rescued with CplxI mutants to those rescued with WT CplxI. The expression levels of all tested CplxI mutants in neurons were 8-13 times higher than that of endogenous CplxI ( Supplementary Fig. 1 ), and they were all properly targeted to the presynaptic terminals ( Supplementary  Fig. 2 online) . We normalized the data to the mean values of the corresponding WT CplxI rescue to allow for comparison of different CplxI mutants across different experiments. To better assess intermediate phenotypes associated with partial-loss-of-function CplxI mutants, we often included CplxI/II DKO neurons rescued with enhanced green fluorescent protein (EGFP) only, as negative controls. In Figures 4 and 5, we pooled all the data from CplxI/II DKO neurons during the entire study, as the normalized CplxI/II DKO values did not vary significantly across different experiments and cultures (P 4 0.05 for all groups).
We first examined P vr and paired-pulse ratio. Overexpression of WT CplxI fully rescued the reduced P vr and increased paired-pulse ratio in CplxI/II DKO neurons (Figs. 1 and 4). Comparable full rescue activity was obtained with D29V mutant (Fig. 4c,d ), which bound the SNARE complex normally (Fig. 3b,c) . R59H mutant showed reduced SNAREbinding activity (Fig. 3b,c) , and CplxI/II DKO neurons rescued with this mutant showed decreased release, indicating a partial loss of function for R59H (Fig. 4c,d ). Release was further reduced in CplxI/II DKO neurons rescued with the double mutant R48L R59H (Fig. 4c,d ). The double mutant K69A Y70A, which completely lacks SNARE complex binding ( Fig. 3d) , had almost no rescue activity, as the P vr and paired-pulse ratio did not differ significantly from those of CplxI/II DKO neurons (P ¼ 0.8 and P ¼ 0.5, respectively; Fig. 4c,d ). We observed a similar rescue pattern when we assayed the Ca 2+ sensitivity of synchronous release (Fig. 4b ,e,f). The strong correlations between our biochemical and electrophysiological data provide in vivo evidence that the SNARE complex interaction of CplxI is essential for its key role in promoting fast neurotransmitter release, and that the SNARE complex itself is important in this process. 
SNARE complex binding is not sufficient for CplxI function
To examine whether SNARE complex binding is sufficient for CplxI function or whether the N-and C-terminal sequences outside the central a-helix contribute to CplxI function, we generated a CplxI deletion mutant, CplxI 47-75 , containing only the minimal SNARE complex-binding region (Fig. 5a ). When we introduced this CplxI fragment into CplxI/II DKO neurons, we found strongly impaired rescue activity ( Supplementary Fig. 3 online), but CplxI 47-75 also showed reduced binding to the SNARE complex (Fig. 5b) , which complicated the interpretation of its reduced rescue activity. Therefore, we generated CplxI truncation mutants lacking either the N terminus (CplxI 47-134 ) or the C terminus (CplxI 1-75 ). CplxI bound normally to the SNARE complex, and the binding of CplxI 47-134 was only slightly reduced (Fig. 5b) . We found that CplxI 1-75 had normal rescue efficacy (data not shown) and CplxI showed an impaired rescue activity as compared to WT CplxI ( Fig. 5c-f, Supplementary Fig. 3 ). These results indicate that the SNARE complex interaction is necessary but not sufficient for CplxI function.
Dual roles of CplxI N terminus in transmitter release
To dissect the regulatory function of the N-terminal domains of CplxI, we generated a CplxI N-terminal truncation mutant that lacks the first 26 residues but includes the accessory a-helix, CplxI (Fig. 5a ). This mutant bound the SNARE complex normally (Fig. 5b) . To our surprise, we found a complete-loss-of-function phenotype when we attempted to rescue CplxI/II DKO neurons with CplxI 27-134 , a phenotype that was more severe than that resulting from CplxI 47-134 rescue. The P vr (Fig. 5c ) and paired-pulse ratio (Fig. 5d) were 55%
and 162% of control values, respectively, and did not differ significantly from those of CplxI/II DKO neurons (P ¼ 0.4 and P ¼ 0.8, respectively). The Ca 2+ sensitivity was also similar to that of CplxI/II DKO neurons (P ¼ 0.8 for 12 mM Ca 2+ potentiation and P ¼ 0.4 for 1 mM Ca 2+ depression; Fig. 5e ,f). Our CplxI 47-134 rescue experiments suggest that the N-terminal domains of CplxI merely modulate CplxI function. Contrary to this expectation, the results with CplxI imply that the first 26 residues of CplxI are essential for its function. Western blotting and immunocytochemistry revealed that sufficient amounts of CplxI were expressed in neurons and targeted to the presynaptic terminals ( Supplementary Figs. 1 and 2) . The SNARE complex binding of CplxI was also normal (Fig. 5b) . Hence, our results indicate that the central a-helix, the accessory a-helix and the extreme N terminus (residues 1-26) of CplxI have distinct roles in regulating neurotransmitter release. The central a-helix of CplxI binds the SNARE complex to promote release. The accessory a-helix (residues 29-47) has a negative regulatory effect on vesicle fusion, whereas the first 26 residues have a strong positive effect. According to this interpretation, the N-terminal deletion mutant CplxI 47-134 loses both the positive function of the first 26 residues and the negative function of the accessory a-helix. Therefore, it may show more rescue activity than CplxI in CplxI/II DKO neurons. Indeed, all tested synaptic parameters of CplxI/II DKO neurons rescued with CplxI 47-134 were significantly different from those of CplxI/II DKO neurons rescued with CplxI 27-134 (P o 0.001 for all of P vr , paired-pulse ratio and Ca 2+ sensitivity; Fig. 5c-f) . These results also confirm that SNARE complex binding is not sufficient for CplxI function and that the N-terminal sequences of CplxI contribute to its function. Inhibitory function of the accessory a-helix of CplxI Our results demonstrate that CplxI has an overall positive effect in promoting synaptic vesicle fusion, whereas the accessory a-helix inhibits Ca 2+ -triggered release. To gain insight into the molecular mechanism underlying the inhibitory function of the accessory a-helix, we generated a CplxI variant (CplxI 41-134 ) with the accessory a-helix partially truncated (Fig. 5a ). CplxI 41-134 bound the SNARE complex like WT CplxI (Fig. 5b) . CplxI/II DKO neurons rescued with CplxI 41-134 showed a partial-loss-of-function phenotype ( Fig. 5c-f Fig. 5c-f) . Thus, the inhibitory function of the accessory a-helix requires the complete accessory a-helical structure.
To examine whether the inhibitory function of the accessory a-helix is dependent on its a-helical conformation, we made use of a helixbreaking mutation in this region, L41P. To verify the effect of this mutation, we generated a recombinant CplxI variant comprising residues 26-83 with the L41P mutation (CplxI 26-83 L41P) and acquired a series of NMR spectra of CplxI 26-83 L41P in isolation or bound to the SNARE complex. The structural data indicated that the L41P mutation caused few changes in the SNARE complex-binding mode of CplxI but strongly perturbed the accessory a-helix (see Supplementary Data and Supplementary Fig. 4 online) .
When we rescued CplxI/II DKO neurons with CplxI 27-134 L41P, we found similar effects to those of CplxI 41-134 and CplxI 47-134 . The P vr , paired-pulse ratio and Ca 2+ sensitivity were only modestly impaired as compared to WT CplxI (Fig. 5c-f) . The rescue activity of CplxI L41P was significantly greater than that of CplxI 27-134 (measured by P vr , paired-pulse ratio and Ca 2+ sensitivity; P o 0.05 for all; Fig. 5c-f) . Collectively, these results demonstrate that the inhibitory function of the accessory a-helix is dependent on the integrity of the a-helical conformation.
CplxI N-terminal functions require SNARE complex binding
We next attempted to define the relationship between SNARE complex binding and the functions of the N-terminal domains of CplxI. Given the WT-like SNARE complex binding of CplxI and its lossof-function phenotype in rescue experiments, we reasoned that CplxI 27-134 would be able to compete with WT CplxI for SNARE complex binding and thereby inhibit release in WT neurons. To test this hypothesis, we overexpressed CplxI in WT (or CplxII KO) neurons and compared these to WT (or CplxII KO) neurons overexpressing WT CplxI. We found that overexpression of CplxI resulted in a 32% reduction in P vr , a 32% increase in paired-pulse ratio and decreased Ca 2+ sensitivity (Fig. 6) . These data showed that overexpression of CplxI 27-134 reduced Ca 2+ -triggered fast neurotransmitter release in WT neurons, but not to the extent observed upon rescue of CplxI/II DKO neurons with CplxI (Fig. 5) , most probably because in the former case, the endogenous CplxI still participated in release. Consistent with this idea, overexpression of CplxI in CplxI Het CplxII KO neurons caused stronger phenotypic changes than in WT neurons (data not shown).
We next introduced the K69A Y70A double mutation, which abolishes SNARE complex binding (Fig. 3d) , into CplxI . We found that the K69A Y70A mutation completely prevented the inhibitory effect of CplxI in WT neurons. Overexpression of CplxI 27-134 K69A Y70A in WT neurons did not alter P vr , paired-pulse ratio or Ca 2+ sensitivity (Fig. 6) . Thus, CplxI must first bind the SNARE complex to execute the additional functions through its N-terminal domains (the first 26 residues and the accessory a-helix). These results also confirmed that CplxI 27-134 is indeed a loss-of-function mutant and its failure to rescue CplxI/II-DKO neurons is not a trivial artifact. It is noteworthy that the sequential actions of the SNARE complex-binding region and the N-terminal domains of CplxI could be revealed only by these overexpression experiments in WT neurons and not by the rescue experiments in CplxI/II DKO neurons, because CplxI 27-134 and CplxI K69A Y70A behaved similarly in CplxI/II DKO neurons (Figs. 4 and 5) .
Both CplxI and CplxI K69A Y70A led to complete-loss-offunction phenotypes when expressed in CplxI/II DKO neurons, but the underlying mechanisms are different. The CplxI K69A Y70A phenotype results from the loss of CplxI functions altogether, as the functions of the N-terminal domains depend on the SNARE complex interaction. In contrast, the CplxI 27-134 phenotype is due to the absence of the facilitatory function of the first 26 residues while the remaining positive effect of the central a-helix is counteracted by the inhibitory effect of the accessory a-helix. This idea predicts that removal of the inhibitory function of the accessory a-helix in CplxI would reduce the inhibitory effect of this CplxI variant in WT neurons, as it did in the rescue experiments. Indeed, when we overexpressed CplxI 41-134 or CplxI 27-134 L41P in WT neurons, we found that CplxI 41-134 caused little change in transmitter release, and CplxI 27-134 L41P had only a subtle effect (Fig. 6) . Together with the results from the rescue experiments, these overexpression studies confirmed that the accessory a-helix inhibits Ca 2+ -triggered synchronous release and the first 26 residues facilitate it.
CplxI N terminus facilitates transmitter release in Syt1 KO The phenotypic similarity between CplxI/II DKO and Syt1 KO indicates that complexins and Syt1 may function in the same pathway. We therefore tested the hypothesis that the CplxI N terminus functionally interacts with Syt1 and that the loss-of-function phenotype of CplxI 27-134 is due to the lack of this interaction. If this were the case, CplxI and WT CplxI would behave similarly in the absence of Syt1. Hence, we overexpressed WT CplxI or CplxI in Syt1 KO 77 32 38 33  43  30  21  29  51 29 21 30 Norm. P neurons and compared these to Syt1 KO neurons expressing EGFP only. Typically, neurotransmitter release in hippocampal glutamatergic neurons can be separated into two components on the basis of their time constants, a fast component with a time constant of 6-7 ms (synchronous release) and a slow component with a time constant of 200-300 ms (asynchronous release) 31, 32 . We found that in all of these Syt1 KO neurons, both the time constant and the amplitude of the synchronous release differed from those of WT neurons (Fig. 7a) . When we measured evoked EPSC amplitude, EPSC charge and P vr , we found no significant changes upon overexpression of WT CplxI in Syt1 KO neurons (P 4 0.05 for all three parameters; Fig. 7b-d) . However, overexpression of CplxI in Syt1 KO neurons caused substantial reductions in evoked EPSC amplitude, EPSC charge and P vr as compared with Syt1 KO neurons overexpressing WT CplxI or EGFP (Fig. 7b-d) . The similar inhibitory effects of CplxI in both WT and Syt1 KO neurons contradict the idea that the loss-of-function phenotype of CplxI 27-134 is due to lack of interaction with Syt1. Rather, these results indicate that the N terminus of CplxI can facilitate Ca 2+ -triggered neurotransmitter release even in the absence of Syt1. The Ca 2+ -triggered release in Syt1 KO neurons can still be mathematically separated into two kinetically distinct components, a fast component with a time constant of 30-50 ms and a slow component with a time constant of 300-400 ms (data not shown and refs. 24,32). When we separated these two release components, we found that overexpression of WT CplxI or CplxI did not change the time constants of the fast and slow components. The reduction of P vr by overexpression of CplxI in Syt1 KO neurons was primarily due to a decrease in the magnitude of the fast component, and the slow component was only slightly affected (data not shown). Notably, the inhibitory effect of CplxI in Syt1 KO neurons seems more pronounced than in WT neurons ( Fig. 6a and Fig. 7d ), suggesting that Syt1 may partially relieve the inhibitory function of the accessory a-helix.
DISCUSSION
Ca 2+ -triggered neurotransmitter release is the most tightly regulated membrane fusion reaction. It is controlled by complex protein machinery involving the minimal fusion apparatus and specialized proteins that exquisitely fine-tune the speed and Ca 2+ sensitivity of transmitter release. To achieve this fast and sophisticated regulation, this machinery is probably suspended in a metastable state that involves a delicate balance between activating and inhibiting interactions. It would be biologically feasible for some components of the release machinery to participate in both types of interactions, acting as both activators and inhibitors of release. Model for complexin function in Ca 2+ -triggered neurotransmitter release. During priming (transition from step 1 to 2), the SNARE complex forms in the N-to C-terminal direction. However, the 'zippering' process is not complete at this stage, and the C terminus of the SNARE complex is still partially unstructured. Complexins bind this partly assembled SNARE complex through their central a-helix (step 3). Binding of complexins helps stabilize the SNARE complex, which could in part contribute to the positive function of complexins. At the same time, the accessory a-helix occupies the position of the C-terminal portion of the synaptobrevin-2 SNARE motif and thereby hinders full assembly of the SNARE complex before Ca 2+ influx (step 3). Meanwhile, SNARE complex binding of complexins positions the complexin N terminus near the fusion pore to recruit other unknown interaction partners (labeled X) that facilitate vesicle fusion (step 3). After Ca 2+ influx, Ca 2+ -bound Syt1 interacts with phospholipid membrane and the SNARE complex, and fully assembles the SNARE complex (step 4), resulting in fusion-pore opening (step 5). During this process, complexins are displaced from the SNARE complex.
Complexins are key regulators in synaptic exocytosis. Previous studies have revealed either a positive 9,16-18 or a negative [19] [20] [21] [22] [23] effect of complexins on exocytosis, resulting from different manipulations that simply increase or decrease complexin abundance in various systems. In the present study, we have dissected the distinct roles of different CplxI domains in controlling Ca 2+ -triggered fast release. We show that CplxI facilitates transmitter release through its SNARE complex-binding region and its first 26 residues, whereas the accessory a-helix has an inhibitory effect on vesicle fusion. Our data demonstrate that complexins have an overall positive function in promoting transmitter release and emphasize their dual role in fine-tuning the release process. These results reveal a structural basis that can account for both the facilitating and inhibitory functions of complexins in Ca 2+ -triggered release, and lead us to propose a model for the molecular mechanism of complexin function that differs from previous models 12, 16, [21] [22] [23] in several aspects (Fig. 8) .
Role of CplxI binding to the SNARE complex Our studies of SNARE complex binding-deficient CplxI mutants provide the missing link between the in vitro complexin-SNARE complex interaction and in vivo complexin function. The clear correlation between SNARE complex binding and CplxI function (Fig. 4 ) strongly supports the notion that complexins promote synaptic vesicle fusion at least in part through their binding to the SNARE complex. Two mechanisms may contribute to the essential role of this binding in CplxI function. First, this interaction stabilizes the interface between synaptobrevin-2 and syntaxin-1. This stabilizing effect of CplxI has been shown to extend beyond the CplxIbinding region and propagate toward the C terminus of the SNARE complex, which has led to the hypothesis that CplxI stabilizes the assembled SNARE complex in preparation for fusion 12 . However, this hypothesis has yet to be validated. Second, and perhaps more importantly, CplxI binds the SNARE complex and subsequently recruits other molecular interactions to facilitate the release process. This notion emerges from the key finding that CplxI promotes fusion through its first 26 residues, which do not contact the SNARE complex, and that this function is dependent on SNARE complex binding (Figs. 5 and 6 ). In the context of this discovery, the SNARE complex seems to serve as a scaffold that properly positions the N terminus of CplxI near the fusion pore to stimulate fast release. CplxI might also be able to recruit additional interaction partners via residues within the SNARE complex-binding region that do not contact the SNARE complex. Considering that full assembly of the SNARE complex C terminus is likely to occur during the Ca 2+ -triggering step 33 , we propose that complexins help to assemble the SNARE complex more fully but do not complete SNARE complex assembly (Fig. 8 , transition from step 2 to step 3).
Inhibitory function of the accessory a-helix of CplxI A fusion-clamp role for complexins has been proposed on the basis of in vitro studies of membrane fusion 21, 22 , but several observations show that complexins do not act solely as fusion clamps in transmitter release. First, deletion of CplxI and CplxII in hippocampal neurons greatly reduces Ca 2+ -triggered synchronous release 16 . This is unlikely to be due to the presence and clamp action of CplxIII, because overexpression of CplxIII rescues the CplxI/II DKO phenotype 9 . Second, the fusion-clamp hypothesis 21, 22 predicts that increasing or decreasing complexin abundance in the absence of Syt1 should inhibit or enhance release, respectively. Instead, we found that overexpression of WT CplxI in either WT or Syt1 KO neurons did not inhibit transmitter release (Figs. 2 and 7) . Moreover, deletion of CplxI and CplxII in Syt1 KO neurons further reduced the release as compared to Syt1 KO (M.X. and C.R., unpublished data). Third, although overexpression of CplxI in WT neurons led to a reduction in release (Fig. 6) , we do not consider CplxI to be a fusion clamp. Rather, we view CplxI 27-134 as a loss-of-function mutant lacking the facilitating function of the first 26 residues, because overexpression of CplxI in CplxI/II DKO neurons did not further reduce release as compared to CplxI/II DKO neurons (Fig. 5) . Nevertheless, the inhibition of fusion by complexins in in vitro assays may reflect the negative regulatory role of the accessory a-helix that we have identified here. Our results indicate that the inhibitory function of the accessory a-helix of CplxI depends on its helical conformation (Figs. 5 and 6) . The crystal structure of the CplxI-SNARE complex shows that the accessory a-helix of CplxI is located immediately above the C-terminal portion of the synaptobrevin-2 SNARE motif 12 . Hence, we speculate that the accessory a-helix can replace the C-terminal portion of the synaptobrevin-2 SNARE motif in the four-helix bundle and, together with the repulsion between the synaptic vesicle and the plasma membrane, can prevent the complete assembly of the SNARE complex before the Ca 2+ influx (Fig. 8, step 3 ).
Facilitating function of CplxI in the absence of Syt1
It has been proposed that binding of complexins to the SNARE complex stabilizes primed vesicles in a metastable state and that Syt1 acts on this fusion intermediate to trigger synchronous release 12, 23, 26 . This model implies that complexins function upstream of Syt1. However, we have identified the first 26 residues of CplxI as a novel facilitator of Ca 2+ -triggered fast release that can act in the absence of Syt1 (Fig. 7) . The mechanism underlying this process is currently unknown. The first 26 residues may interact with other proteins, CplxI itself or even lipids. For instance, intramolecular interaction of the first 26 residues with the accessory a-helix, the central a-helix or both could help to relieve the inhibitory effect of the accessory a-helix. However, yeast two-hybrid screens and affinitypurification experiments have so far not identified a specific interacting protein (K.R. and N.B., unpublished data). It is also possible that the extreme N terminus of CplxI interacts with the phospholipid membrane and contributes to stabilization of the stalk or perturbation of the bent membrane at the contact site between the vesicle and the plasma membrane. Currently, it is also unclear whether the positive function of the first 26 residues is coupled to Syt1 in WT synapses but works in conjunction with other Ca 2+ sensors in the absence of Syt1. This facilitating function of the first 26 residues does not involve SNARE complex binding and can occur independently of Syt1 (Fig. 8,  steps 3 and 4) . Therefore, the reason that in vitro fusion assays using SNAREs and Syt1 have detected only the inhibitory effect of complexins 21, 22 may be because the facilitating interaction via the N terminus of complexins is missing in these reductionistic systems.
In addition to shedding light on the molecular mechanisms of complexin function, our study also supports the notion that the SNARE complex is essential for Ca 2+ -triggered fast transmitter release. Numerous genetic and biochemical studies have demonstrated the essential functions of individual SNARE proteins in synaptic vesicle fusion 1 . It has been proposed that the assembly of the SNARE complex drives membrane fusion 34, 35 , but in vivo evidence for the involvement of the SNARE complex in transmitter release is limited 33, 36, 37 . We demonstrate here that binding of CplxI to its receptor, the assembled SNARE complex, is crucial for fast transmitter release, thus providing in vivo evidence for the importance of the SNARE complex in vesicle fusion. Furthermore, the SNARE complex-bound CplxI not only modulates the SNARE complex but apparently also recruits additional interaction partners. This indicates that, in addition to its key role in fusion, the SNARE complex functions as a scaffolding platform to recruit other factors into the release apparatus.
METHODS
Random mutagenesis and cosedimentation assays. Random mutagenesis experiments were done according to published procedures 30 , either with limiting amounts of dGTP (20 mM) or with limiting amounts of dGTP (20 mM) and an excess of dITP (200 mM). PCR was done using specific rat CplxI primers with engineered BamHI or EcoRI sites. PCR fragments were subcloned into pCR2.1-TOPO (Invitrogen), sequenced to identify mutations and then subcloned into pGEX-KG 38 . The resulting vectors expressed WT or mutant CplxI in frame with the GST gene in Escherichia coli. Recombinant GST-CplxI fusion proteins were immobilized and purified on glutathioneagarose (Sigma) and used for cosedimentation assays as described 9 . These procedures are described in detail in the Supplementary Methods online.
SFV constructs and production. Rat WT, mutant CplxI variants or Myctagged CplxI variants were cloned into a bicistronic SFV expression vector (based on pSFV1; Invitrogen) to create vectors containing the respective CplxI complementary DNA followed by a papillomavirus internal ribosome entry site (IRES) and the EGFP-encoding cDNA (from pEGFP-N1; Clontech). Myctagged CplxI variants were generated by fusing a linker (SGGSGGTGG) followed by the Myc epitope (EQKLISEEDL) to the C terminus of CplxI variants. The resulting constructs coexpress the respective CplxI variants with EGFP in the same cell, which allows the identification of infected neurons. Virus particle production, activation and infection were done according to published protocols 27 .
Animals and neuronal culture. CplxI/II DKO mice were obtained by interbreeding of mice homozygous for the CplxII mutation and heterozygous for the CplxI mutation as described 16 . All procedures for maintenance and use of these mice were approved by the Institutional Animal Care and Use Committee for Baylor College of Medicine and Affiliates and by the local government agency of the Max Planck Institute of Experimental Medicine. For electrophysiology experiments, microislands were made by coating collagen (0.7 mg ml -1 ) and poly(D-lysine) (0.1 mg ml -1 ) on coverslips with a custom-built stamp to achieve uniform size (B200-mm diameter). Astrocytes were grown on microislands for 1 week before plating of neurons. Primary hippocampal neurons were prepared from mice on postnatal day 0, plated at a density of 300 cm -2 and grown in a chemically defined medium (Neurobasal-A medium supplemented with Glutamax and B-27; Invitrogen). Under these conditions, a single neuron on an astrocyte microisland forms recurrent synapses (autapses) 39 . For western blotting and immunocytochemistry of protein expression, neurons were plated at densities of 10,000 cm -2 and 5,000 cm -2 , respectively, on continental astrocyte feeder layer.
Western blotting and immunocytochemistry. Proteins were extracted 10-11 h after neurons were infected with SFV. Expression levels of WT and mutant CplxI variants were estimated by western blotting. Neurons were fixed with 4% (w/v) paraformaldehyde 10 h after SFV infection. The presynaptic targeting of WT and mutant CplxI variants were examined using immunocytochemistry and confocal microscopy. These procedures are described in detail in the Supplementary Methods.
Electrophysiology of autaptic hippocampal neurons. In each experiment, approximately equal numbers of glutamatergic neurons from every group were measured in parallel on the same day in vitro (day 9-14 in vitro). Only the microislands containing a single neuron were used for experiments. Whole-cell voltage-clamp recordings were performed between 9 and 12 h after neurons were infected with SFV. The neurons were clamped at -70 mV with an Axopatch 200B amplifier (Molecular Devices) under the control of Clampex 9.2 or 10.0 (Molecular Devices). The data were acquired at 10 kHz and low-pass filtered at 5 kHz. The series resistance was compensated about 80% and only cells with series resistances below 10 MO were analyzed. The patch pipette solution contained 146 mM potassium gluconate, 17.8 mM HEPES, 1 mM EGTA, 0.6 mM MgCl 2 , 4 mM ATP-Mg, 0.3 mM GTP-Na, 12 mM phosphocreatine and 50 U ml -1 phosphocreatine kinase (300 mOsm, pH 7.4). The standard extracellular solution contained 140 mM NaCl, 2.4 mM KCl, 10 mM HEPES, 10 mM glucose, 4 mM CaCl 2 , 4 mM MgCl 2 (300 mOsm, pH 7.4). For measurements of Ca 2+ sensitivity, Mg 2+ concentration was kept at 1 mM and Ca 2+ concentration varied as indicated. Hypertonic solution for measuring RRP size was made by adding 500 mM sucrose to the standard extracellular solution 28 . Fast solution exchange was archived with a microperfusion device (SF-77B, Warner Instruments).
Action potential-evoked EPSC was triggered by a 2-ms somatic depolarization to 0 mV. Neurons were stimulated at 0.2 Hz in standard extracellular solution to measure basal EPSCs. RRP size was determined by measuring the charge transfer of the transient synaptic current induced by a pulsed 4-s-long application of hypertonic sucrose solution directly onto the neuron. To obtain vesicular release probability (P vr ), the evoked EPSC and the response to the hypertonic sucrose solution were recorded successively from the same neuron. Evoked EPSC was integrated for 1 s to calculate the charge transfer. P vr was calculated as the ratio of evoked EPSC charge to RRP size. Short-term plasticity was examined by evoking five EPSCs at 50 Hz in standard extracellular solution, and paired-pulse ratio was measured by dividing the second EPSC amplitude by the first EPSC amplitude. To examine the apparent Ca 2+ sensitivity of synchronous release, EPSCs were evoked at 0.2 Hz in different Ca 2+ concentrations (12 or 1 mM). Each test measurement was preceded and followed by a measurement in standard extracellular solution to control for the rundown of synaptic responses. The EPSC amplitude at each Ca 2+ concentration was normalized to the amplitude in standard extracellular solution 16 . All experiments were performed at room temperature (23-24 1C) .
Data analysis and statistics. Data were analyzed offline using AxoGraph 4.9 or AxoGraph X 1.0 (AxoGraph Scientific). Statistical significances were tested using Student's t-test, the nonparametric Mann-Whitney test or one-way analysis of variance.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
